Expand All |
Collapse All
- Biocompatibility Testing
more info >>
All samples submitted for biocompatibility testing should be sterilized under the same conditions that will be used for the final product. Extracts and extraction conditions must be specified when samples are submitted for testing. If you cannot submit sterile samples, please select the appropriate sterilization process.
- Sterilization Processes for Biocompatibility Test Samples
more info >>
| 5994 |
Ethylene Oxide (100% ETO – 12 hour cycle) |
| 6001 |
E-beam or Gamma Sterilization (~ 25 kGy) |
| 6000 |
Steam Sterilization (121°C for 15 to 30 minutes) |
| 5990 |
Chemical Sterilization |
| |
|
- Biocompatibility Testing – In Vitro Procedures
- Cytotoxicity (Tissue Culture)
more info >>
| 6521 |
Elution Test – ISO - L929 Cells (triplicate plates) |
| 6522 |
Agar Diffusion – ISO - L929 Cells (triplicate plates) |
| 6523 |
Direct Contact – ISO - L929 Cells (triplicate plates) |
| |
|
| 6540 |
Elution Test – USP - L929 Cells (duplicate plates) |
| 6541 |
Agar Diffusion – USP - L929 Cells (duplicate plates) |
| 6542 |
Direct Contact – USP - L929 Cells (duplicate plates) |
| |
|
| 6537 |
Cell Viability Quantification and % Reactivity |
| 6538 |
Surface Area Calculation and Sample Preparation
– This may be required for elution testing of complex devices. |
| |
|
- Inhibition of Cell Growth
-
| 6525 |
1 Dose Level (L929 Cells) |
| 6526 |
ICH - additional dose |
| |
|
- Hemocompatibility Testing
more info >>
| Hematology – In Vitro |
| 6512 |
Hemolysis – Direct Contact, Rabbit Blood (duplicate tubes) |
| 6550 |
Hemolysis – Direct Contact, Rabbit Blood (triplicate tubes) |
| 6513 |
Hemolysis – Sample Extract, Rabbit Blood (duplicate tubes) |
| 6551 |
Hemolysis – Sample Extract, Rabbit Blood (triplicate tubes) |
| 6575 |
JP Hemolysis Test |
| 6548 |
Hemolysis – ASTM Direct Contact |
| 6549 |
Hemolysis – ASTM Elution |
| |
|
| Coagulation – In Vitro |
| 6536 |
Prothrombin Time Test (PT) |
| 6537 |
Partial Thromboplastin Time Test (PTT) |
| |
|
| Complement System |
| 6511 |
Complement Activation Assay |
| |
|
| Platelets |
| 6539 |
Platelet Aggregation |
| |
|
- Genotoxicity Testing
more info >>
| 6530 |
Ames Mutagenicity Test – Five strains, saline or DMSO Extracts |
| 6517 |
Mouse Lymphoma |
| 6518 |
Chromosomal Aberration |
| 6519 |
Mouse Micronucleus Assay |
| |
|
| Other genotoxicity tests are available – please inquire. |
- Biocompatibility Testing – In Vivo Procedures
- Systemic Toxicity – Acute
more info >>
| 7209 |
Systemic Injection Test – USP
– plastics or elastomeric closures, per extract |
| 7263 |
Systemic Injection Test – JP
– plastics or elastomeric closures, per extract |
| 7198 |
Material Mediated Pyrogen – Sham Test (per rabbit) |
| |
|
- Intracutaneous and Irritation Tests
more info >>
| 7210 |
Intracutaneous Tests – USP (2 rabbits)
– plastics or elastomeric closures, per extract |
| 7925 |
Intracutaneous Test – ISO (3 rabbits) |
| 7282 |
Primary Eye Irritation (FHSA guidelines)
– 6 rabbits, 24, 48, and 72 hour observations |
| 7284 |
Primary Skin Irritation (FHSA guidelines)
– 6 rabbits, 24 and 72 hour observations |
| 7920 |
Intraocular Irritation |
| 7232 |
Oral Mucosa Irritation Test (includes histology) |
| 7235 |
Vaginal Irritation Test – ISO (6 rabbits, includes histology) |
| 7285 |
Ocular Irritation Test – ISO
– 3 rabbits, 1, 24, 48, and 72 hour observations |
| 7286 |
Skin Irritation Test – ISO
– 3 rabbits, 1, 24, 48, and 72 hour observations |
| |
Other Mucosal Irritation Studies |
| |
|
- Skin Sensitization Studies
more info >>
| 7501 |
Closed Patch Test (ISO) |
| 7502 |
Buehler Method (EPA) |
| 7507 |
Dose Level Determination |
| 7503 |
Maximization Test – Magnusson Kligman Method (12 test guinea pigs)** |
| 7505 |
Maximization Test – Magnusson Kligman Method (11 test guinea pigs)**
– Each additional guinea pig |
| 7510 |
Re-challenge (including 5 naive controls) |
| 7508 |
Positive Controls (historical validation) |
| 7509 |
Positive Controls (concurrent) |
| 7512 |
Murine Local Lymph Node Assay (LLNA) (includes positive control) |
| |
|
* These tests include historical positive controls. A positive control group is a group treated with a known sensitizing agent. A positive control group must be included with a sensitization test to demonstrate that a sensitization response can be elicited under the conditions of the test. There are two types of positive controls. A concurrent positive control group is one conducted at the same time as a particular test. Alternatively, Pacific BioLabs runs a historical positive control group at least once a year. Any test performed during the year under the same conditions can be compared to this control. The historical control minimizes cost and the use of animals.
** The Maximization Test using 12 test animals is recommended for all critical sensitization determinations. The larger test group size allows for a more accurate assessment of sensitization potential and has a lower incidence of false positives.
- Thrombosis – In Vivo
-
| 6516 |
ISO Dog Thrombogenicity Testing |
| |
|
- ISO Intramuscular Implant Test – 3 rabbits *
-
| 7930 |
7 day observation period |
| 7931 |
14 day observation period |
| 7932 |
30 day observation period |
| 7933 |
60 day observation period |
| 7934 |
90 day observation period |
| 7935 |
180 day observation period |
| 7936 |
365 day observation period |
| 7230 |
Histopathology of Implant Sites (required) |
| |
|
- Intramuscular Implant Test – 2 rabbits *
- Classification of Plastics Tests – USP (Class I to VI)
more info >>
| 7220 |
Class I |
| 7221 |
Class II |
| 7222 |
Class III |
| 7223 |
Class IV (includes 7 day implant) |
| 7225 |
Class V |
| 7227 |
Class VI (includes 7 day implant) |
| |
|
- Subacute/Subchronic Toxicity (OECD/ISO)
more info >>
| 7233 |
IP Subacute Toxicity with Histopathology |
| 7234 |
IV Subacute Toxicity with Histopathology |
| 7258 |
IP Subchronic Toxicity with Histopathology |
| 7259 |
IV Subchronic Toxicity with Histopathology |
| 7299 |
Preclinical Device Evaluation – Surgical Procedures (surg_models.asp) |
| |
|
- Contact Lens and Ophthalmic Product Studies
-
| 7290 |
21 Day Ocular Irritation
– includes corneal oxygen metabolism determination |
| 7291 |
Microbiological Validation of Lens Disinfection Regimen |
- Pyrogen And Biological Safety Tests
- Pyrogen Tests
more info >>
| United States Pharmacopeia (USP) |
| 7201 |
3 Rabbit Test (non-pyrogenic) |
| 7202 |
Retest 5 Rabbits |
| 7236 |
Sham Test (per rabbit) |
| 7198 |
Material Mediated Pyrogen |
| |
|
| For substances determined to be pyrogenic, there will be an additional charge of $45.00 per rabbit. |
| |
|
- Safety Tests
more info >>
| 7204 |
USP Safety Test (mice) |
| 7219 |
EP Safety Test (mice) |
- Water Testing
more info >>
- Chemical and Physical Tests
-
| 3131 |
Purified Water Monograph – USP (conductivity and TOC) |
| 3980 |
Total Organic Carbon (TOC) |
| 3150 |
Particulate Matter (2 to 100 microns) – Light Obscuration Method |
| 6560 |
LAL – Bacterial Endotoxins Test – Kinetic Chromogenic or Turbidimetric |
| |
|
- Microbiological Analyses – Water
- Water Sampling Supplies
-
| 1379 |
Polycarbonate Bottle, 1 Liter
(For each purified water monograph, fill one bottle to capacity.) |
| 1380 |
Glass Bottle with Teflon Lined Cap, 1 Liter (reusable)
(For each purified water monograph, fill one bottle to capacity.) |
| 1368 |
Specimen Cups, Sterile, 120 mL
(For each microbiological analysis, fill one cup to capacity.) |
| 1383 |
TOC Sample Vials, 40 mL
(For each TOC test, fill 2 vials to capacity.) |
| 1384 |
Test Tubes, Sterile, Non-pyrogenic, 15 mL
(For each LAL test, fill one tube to capacity.) |
- Microbial Environmental Monitoring
more info >>
| 6301 |
Environmental Survey – Microbiological (Performed by Pacific BioLabs Personnel) |
| |
|
- Microbial Environmental Monitoring Supplies
- Microbial Samples – Incubation, Enumeration and Report
more info >>
| 1360 |
Fallout Plate Count |
| 1361 |
Contact Plate Count |
| 1362 |
Biotest Air Sampler Strip Count |
| 1363 |
Buffer Solution – Aerobic Count (Membrane Filtration) |
| |
| Anaerobic counts available upon request. |
- Microbial Identification
more info >>
For Rush requests, we can have results in 10 to 24 hours. Because of the faster results capability, results reproducibility and the genetic strain tracking feature, Pacific BioLabs recommends the RiboPrinter for bacterial identifications. Discount pricing is available for high volume projects.
In addition to the genetic method, Pacific BioLabs offers alternate techniques for microbial identifications. Following gram stain and morphology of unknown bacteria, an appropriate identification method is selected. The bacteria can be identified by the MIDI method, which is based on a fatty acid profile of an extract of the bacteria, or the API biochemical method.
- Bacterial Identification – RiboPrinter Genetic Method
-
1510 |
Same Day Turnaround Time** |
1511 |
– 1 Day** |
1513 |
– 3 Days |
1517 |
– 7 Days |
1520 |
– 14 Days |
* If > 8 isolates are submitted together, the fee is reduced to the next longer TAT amount.
** Pure fresh culture required for ≤ 1 day TAT.
|
- Bacterial Identification – Other Methods
-
| Gram positive rods – MIDI |
Gram negative rods, Enterobacteriaceae – API |
| Gram positive cocci – AP |
Gram negative rods, other bacteria – MIDI |
1370 |
Bacterial Identification (MIDI GC with gram stain, morphology, catalase and oxidase.)* |
|
– 1 Organism |
|
– 2 to 5 Organisms |
|
– 6+ Organisms |
1371 |
|
|
– 1 Organism |
|
– 2 to 5 Organisms |
|
– 6+ Organisms |
* The initial results of some bacterial identification testing may indicate more than one organism as a possible identification. We can report the results of the initial test or perform additional biochemical confirmation testing to distinguish the most probable organism identification. When additional confirmation testing is required, there will be an additional fee.
| 1323 |
Bacteria Characterization – Biochemical & Morphological |
1324 |
Yeast Identification |
1325 |
Mold Identification |
1332 |
Gram Stain |
1343 |
Gram Negative Bacteria |
1326 |
Microorganism Morphology |
- Device Cleaning And Disinfection
- Biological Indicators
more info >>
- Product Inoculation
-
| 6702 |
B. subtilis (ethylene oxide), 103 to 108/sample |
| 6703 |
G. stearothermophilus (steam), 103 to 106/sample |
| |
|
- Spore Strips
-
| 6401 |
Spore Strip Population Verification – USP Method – 3 spore strips |
| 6404 |
Exposed Spore Strip Population (count unknown) |
| |
|
| |
See "Sterility Assurance Tests" for Sterility testing of exposed biological indicators |
- Sterility Assurance Tests
more info >>
- Bacteriostasis/Fungistasis (Sterility test and dose audit method validation)
more info >>
| Immersion (Direct Transfer) |
| 6100 |
3 organisms – SCDM (Dose Audits) |
| 6101 |
6 organisms – 3 in FTM and 3 in SCDM (USP Sterility Tests) |
6103 |
Membrane Filtration by Vacuum Method |
6104 |
Membrane Filtration by Millipore Steritest™ Method |
| |
|
| 6102 |
Growth Promotion of Media (per organism, in duplicate) |
| |
|
- Bioburden Method Validation – Recovery Study
more info >>
| 6220 |
Exhaustive Recovery (3 – 5 extractions per sample) |
| 6218 |
Simulated Recovery (spore inoculation, per sample) |
| 6230 |
Screening for the Release of Substances Adversely Affecting Bioburden Estimates
(from AAMI/ISO 11737-1: 3 organisms, in triplicate) |
| |
|
- Bioburden Analyses
more info >>
| Total Aerobic Bacteria and Fungi by Membrane Filtration Method |
| 6201 |
Small Devices |
| 6202 |
Medium Size Devices, Small Kits |
| 6203 |
Large Devices, Large Kits, Papers, Fabrics |
| |
|
| 6206 |
Bioburden – Total Aerobic Bacteria by Plate Count Method |
| |
|
| Total Aerobic Bacteria Only by Membrane Filtration Method |
| 6240 |
Small Devices |
| 6241 |
Medium Size Devices, Small Kits |
| 6242 |
Large Devices, Large Kits, Papers, Fabrics |
| |
|
| 6207 |
Bioburden – Total Anaerobic (with Total Aerobic Bacteria and Fungi) |
| 6209 |
Bioburden – Total Aerobic Spores (with Total Aerobic Bacteria and Fungi) |
| |
| Unless otherwise requested, the membrane filtration method will be used for all samples with filterable extracts. |
| |
|
| 6204 |
Bioburden – Packaging (Contact Plate) |
| 6205 |
Bioburden – Packaging (Swab/Membrane Filtration) |
| 6210 |
Bioburden – Process Fluids (Membrane Filtration) |
| 1335 |
Bioburden – Water (Aerobic Bacteria by Membrane Filtration) |
- Sterilization Validations
more info >>
| 9756 |
Sterilization Process Validation Protocol Preparation |
| |
|
For initial sterilization process validations, cGMP regulations require a written validation protocol. Pacific BioLabs will customize a sterilization validation protocol to meet individual client requirement. Once the initial validation is successfully completed, no additional validation protocols are normally required for subsequent revalidation (i.e. dose audits, EO cycle revalidation or subsequent single lot validation for the same product using the same method.)
- Radiation Sterilization Validation - Microbiological
more info >>
Initial Validations
In an initial validation, a protocol, bioburden method validation and B/F test (dose audit method validation) are required. Additionally, each of the ANSI/AAMI/ISO methods also requires bioburden testing: 10 samples for single lot validations or 30 samples for frequently produced lots (10 samples from each of 3 lots). To complete the initial testing, each method requires either a dose audit of sublethally irradiated samples: 100 samples for Methods 11137-2 Method 1 and 15844 or 10 samples for VDmax. For large samples that do not fit into sterility test containers, SIP preparation is also required.
Revalidation – Quarterly Dose Audits
In quarterly dose audits, bioburden of 10 samples and a dose audit (AAMI/ISO Dose Audit) of sublethally irradiated samples are required. If SIP preparation (sterility_tests.asp#Sample Item Portion (SIP) Preparation) was required in the initial validation, it will be required for any revalidation.
- Radiation Sterilization Validation – VDmax
more info >>
| 9756 |
Validation Protocol |
| 9750 |
Sample Item Portion (SIP) Preparation (for large products)
– single lot validation (39 samples)
– complete 3 lot validation (59 samples) |
| 6201-6203 |
Bioburden - Total Aerobic Spores & Fungi
– single lot validation (10 samples)
– complete 3 lot validation (30 samples) |
| 6218, 6220 |
Bioburden Method Validation – Recovery Validation |
| 6230 |
Adverse Substance Screening |
| 6100 |
Bacteriostasis/Fungistasis (Dose Audit Method Validation) |
| |
|
| Dose Audit – 10 samples in SCDM |
| 6802 |
≤ 120 mL |
| 6803 |
500 mL |
| 6804 |
1000 mL |
| 6805 |
2000 mL |
| 6857 |
Verification Dose Calculation Report |
| |
Validation Summary Report (optional) |
| |
|
- Radiation Sterilization Validation – AAMI/ISO 11137-2 Method 1 or AAMI Method 15844
more info >>
| 9756 |
Validation Protocol |
| 9750 |
Sample Item Portion (SIP) Preparation (for large products)
– 132 samples (AAMI 15844)
– 152 samples (AAMI 11137) |
| 6201-6203 |
Bioburden - Total Aerobic Spores & Fungi
– single lot validation (10 samples)
– complete 3 lot validation (30 samples) |
| 6218, 6220 |
Bioburden Method Validation – Recovery Validation |
| 6230 |
Adverse Substance Screening |
| 6100 |
Bacteriostasis/Fungistasis (Dose Audit Method Validation) |
| |
|
| Dose Audit – 100 samples in SCDM |
| 6837 |
40 mL |
| 6838 |
120 mL |
| 6839 |
500 mL |
| 6840 |
1000 mL |
| 6841 |
2000 mL |
| 6857 |
Verification Dose Calculation Report |
| |
Validation Summary Report (optional) |
- Ethylene Oxide Cycle Validation – AAMI/ISO Methods
more info >>
A typical EO cycle validation consists of exposure of product and B. subtilis biological indicators in fractional and half cycles, followed by sterility testing. The number of samples to be tested varies with the size of the EO sterilization chamber. Fees for sterility testing associated with customized ETO sterilization validation studies will be based on the number of spore strips and products tested, and the media volume required to test product samples. Additional testing normally performed as part of the validation is bioburden, bacteriostasis/fungistasis and ethylene oxide residuals.
- USP Sterility Tests
more info >>
- Product Only – Direct Transfer (Immersion)
- Sterility Testing of Biological Indicators
-
| 6806 |
10 Spore Strips and 1 or 2 positive controls – 15 mL SCDM |
| 6820 |
Each additional spore strip – 15 mL SCDM |
| 6880 |
Self Contained Biological Indicators, 1 – 20 |
| 6881 |
Each additional S.C.B.I. |
- LAL Bacterial Endotoxins Tests – USP
more info >>
- Gel Clot Method
-
| 6499 |
Water |
| 6500 |
Liquids |
| 6502 |
Medical Devices (Immersion, < 1000 mL LAL negative water) |
| 6503 |
Medical Devices (Immersion, > 1000 mL LAL negative water) |
| 6504 |
Medical Devices (Fluid Path, < 1000 mL LAL negative water) |
| 6505 |
Medical Devices (Fluid Path, > 1000 mL LAL negative water) |
| 6509 |
Concurrent Assay of Sample Dilution |
| 6508 |
Non-concurrent Assay of Sample Dilution |
| |
|
The gel clot method is semi-quantitative. For medical devices produced in lots of greater than 100 units, 10 samples are required. One test is performed on a composite of the 10 samples. Typically, the sample composite is tested at half of the client specified endotoxin limit. For cerebrospinal fluid contact, the average device limit in a 10 sample composite test is 2.15 endotoxin units (EU). For most other devices, the average limit in a 10 sample composite test is 20 EU per device. When successful, the interpretation for the test will be reported as follows: "These samples pass the test for bacterial endotoxins at 1/2 the endotoxin limit for medical devices." For liquid samples with an EU level below test system sensitivity limits, the results will be reported as "less than (the test system limit)", e.g. 0.125 EU/mL for high purity water. If an exact EU result is required, a kinetic method must be used.
- Kinetic Turbidimetric or Chromogenic Methods
- LAL Validation – Inhibition and Enhancement
-
| |
| Gel Clot Method |
| 6506 |
LAL Validation (one lot) |
| 6514 |
LAL Validation (three lots, concurrently tested) |
| |
|
| Kinetic Turbidimetric or Chromogenic Methods |
| 6552 |
LAL Validation (one lot) |
| 6554 |
LAL Validation (three lots, concurrently tested) |
- Physical Tests
- Accelerated Aging of Medical Devices – 1 year
- Packaging Tests
more info >>
| 6630 |
Package Expiration Dating Validation Protocol |
| |
|
A typical package expiration dating study includes accelerated aging of packaged products plus packaging tests after each of several aging periods (e.g. 1, 3 and 5 year equivalency). Also, aged products are usually returned to the client for physical evaluation and testing. A laboratory report specifying aging conditions, room temperature equivalency and sample storage dates is provided for each sample return date. We can follow your protocol or write a protocol to meet your specific requirements.
- Environmental Stressing (optional) plus Package Integrity by Dye Penetration
-
| 6602 |
Package Integrity by Dye Penetration |
| |
– 13 sample recommended (10 test samples and 3 positive control)
|
| |
|
- Environmental Stressing (optional) plus Package Integrity by Microbial Challenge
| 6601 |
Package Integrity by Microbial Challenge - Small Device |
| 6606 |
Package Integrity by Microbial Challenge - Medium Device |
| 6607 |
Package Integrity by Microbial Challenge - Complex Device |
| 6608 |
Package Integrity by Microbial Challenge - Large Device |
| |
– B.I. Dust Method: 13 sample recommended (10 test samples and 3 positive control) |
| |
|
| 6640 |
Package Burst Test |
| 6641 |
Package Creep Test |
| 6644 |
Package Distribution Simulation |
| 6646 |
Seal Peel Test |
- Particulate Matter
more info >>
| 3152 |
Light Obscuration Method (2 to 100 microns)
– 1 sample (small medical device)
– 2+ samples (per sample) |
| 3154 |
Microscopic Method (>10 and >25 microns)
– 1 sample (small medical device)
– 2+ samples (per sample) |
| |
|
The medical device is rinsed with filtered water (0.2 µm pore size). The particulate test is run on the rinse water. Usually, results are reported as particles per mL. There is an additional charge for the sample handling required for larger and/or more complex medical devices such as I.V. bags and tubing assemblies.
|